Beta‐blockers for prevention of oesophageal variceal rebleeding in cirrhotic patients
Referencias
Additional references
Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Beta‐adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta‐analysis. Hepatology 1997;25(1):63‐70. [MEDLINE: 8985266]
Cales P, Braillon A, Girod C, Lebrec D. Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats. Journal of Hepatology 1985;1(4):349‐57. [MEDLINE: 4056347]
Cales P, Braillon A, Jiron MI, Lebrec D. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol. Journal of Hepatology 1985;1(1):37‐46. [MEDLINE: 3877112]
Chung S. Management of bleeding in the cirrhotic patient. Journal of Gastroenterology and Hepatology 2002;17(4):355‐60. [MEDLINE: 11982712]
Clarke M, Oxman AD, editors. Cochrane Reviewers’ Handbook 4.2.0 [updated March 2003]. The Cochrane Library. Oxford: Update Software. Updated quarterly, 2003, Issue 2.
D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta‐analytic review. Hepatology 1995;22(1):332‐54. [MEDLINE: 7601427]
D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence‐based approach. Seminars in Liver Disease 1999;19(4):475‐505.
de Franchis R. What have we accomplished?. In: Franchis R editor(s). Portal hypertension III: Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies. First Edition. Oxford: Blackwell Science, 2001:1‐12. [ISBN 0632059184]
DeMets DL. Methods for combining randomised clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341‐50. [MEDLINE: 3616287]
DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88. [MEDLINE: 3802833]
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629‐34. [MEDLINE: 9310563]
Frishman WH. Beta‐adrenergic receptor blockers. Adverse effects and drug interactions. Hypertension 1988;11(3 Pt 2):II21‐9. [MEDLINE: 2895072]
Gaudin C, Braillon A, Poo JL, Moreau R, Hadengue A, Lebrec D. Regional sympathetic activity, severity of liver disease and hemodynamics in patients with cirrhosis. Journal of Hepatology 1991;13(2):161‐8. [MEDLINE: 1744420]
Gluud C. Alcoholic hepatitis: no glucocorticosteroids?. Steatohepatitis (NASH and ASH) ‐ Falk Symposium 121. Lancaster: Kluwer Academic Publisher, 2001:322‐42.
Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80(4):800‐9. [MEDLINE: 6970703]
Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia‐Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99(5):1401‐7. [MEDLINE: 2210246]
Hayes PC, Davis JM, Lewis JA, Bouchier IA. Meta‐analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 1990;336(8708):153‐6.
Heresbach D, Jacquelinet C, Nouel O, Chaperon J, Bretagne JF, Gosselin M. Sclerotherapy versus ligation in hemorrhage caused by rupture of esophageal varices. Direct meta‐analysis of randomized trials [Article in French]. Gastroenterologie Clinique et Biologique 1995;19(11):914‐20. [MEDLINE: 8746051]
International Conference on Harmonisation Expert Working Group. Code of Federal Regulations & International Conference on Harmonization Guidelines. Media: Parexel Barnett, 1997.
Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 2002;122(6):1620‐30. [MEDLINE: 12016427]
Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomised trials in meta‐analyses. Annals of Internal Medicine 2001;135(11):982‐9. [MEDLINE: 11730399]
Lebrec D, Hillon P, Munoz C, Goldfarb G, Nouel O, Benhamou JP. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology 1982;2(5):523‐7. [MEDLINE: 6981575]
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses. Lancet 1998;352(9128):609‐13. [MEDLINE: 9746022]
Pagliaro L, Burroughs AK, Sørensen TIA, Lebrec D, Morabito A, D'Amico G, et al. Therapeutic controversies and randomised controlled trials (RCTs): prevention of bleeding and rebleeding in cirrhosis. Gastroenterology International 1989;2(2):71‐84.
Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, et al. Beta‐adrenergic‐antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco‐Italian Multicenter Study Group. New England Journal of Medicine 1991;324(22):1532‐8. [MEDLINE: 1674104]
Primignani M, Carpinelli L, Sarin KS, Kamath PS. Portal hypertensive gastropathy. In: Franchis R editor(s). Portal hypertension III: Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies. First Edition. Oxford: Blackwell Science, 2001:65‐75.
Pugh RNH, Murray‐Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding esophageal varices. British Journal of Surgery 1973;60(8):648‐52. [MEDLINE: 4541913]
Rosellini SR, Miglio F. Beta‐blockers for the prevention of variceal haemorrhage in patients with cirrhosis: an updated meta‐analysis of randomized controlled trials. Italian Journal of Gastroenterology 1991;23(7):408‐15. [MEDLINE: 1683803]
Rossle M. Prevention of rebleeding from oesophageal‐gastric varices. European Journal of Gastroenterology & Hepatology 2001;13(4):343‐8. [MEDLINE: 11338060]
Sauerbruch T, Wotzka R, Kopcke W, Harlin M, Heldwein W, Bayerdorffer E, et al. Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. New England Journal of Medicine 1988;319(1):8‐15. [MEDLINE: 3288871]
Schulz KF, Chalmers I, Hayer R, Altman D. Empirical evidence of bias. JAMA 1995;273(5):408‐12. [MEDLINE: 7823387]
Schuman BM, Beckman JW, Tedesco FJ, Griffin JW, Assad RT. Complications of endoscopic injection sclerotherapy: a review. American Journal of Gastroenterology 1987;82(9):823‐30. [MEDLINE: 3307389]
